Skip to main content

Our treatment model

Two lasers, two stages of disease.

Hidradenitis suppurativa is two diseases in sequence — an inflammatory disease and a structural one. Our model uses one tool for each. This page explains where the two lasers fit, how we sequence them, and the cases we will not take.

The full picture

Where we fit in the HS treatment ladder

HS care is not a single specialty's responsibility. The full ladder runs from lifestyle to reconstructive surgery, and most patients will sit on several rungs over the course of their disease. We are rungs 3 and 4 — the procedural laser tier between systemic medical therapy and excisional reconstruction.

  1. Lifestyle & topical care

    Patient + primary care

    Smoking cessation, weight management where relevant, gentle antiseptic washes, friction reduction. Foundation, not treatment in isolation.

  2. Systemic medical therapy

    Dermatology / rheumatology

    Oral antibiotics for anti-inflammatory effect, hormonal modulation, and biologic agents (adalimumab, secukinumab). The medical arm of HS control.

  3. Follicle-directed laser therapy

    Us

    Long-pulsed laser sessions that reduce the follicular population driving inflammation. The procedural answer to active disease.

  4. CO₂ laser tunnel closure

    Us

    Tract-by-tract unroofing and ablation of established sinus tracts with substantially less tissue loss than wide excision.

  5. Wide excision & flap reconstruction

    Plastic / general surgery

    For diffuse Hurley III or cases beyond what laser closure can address. We refer when this is the right answer.

Principles

Three principles that govern every plan

01

Match the tool to the tissue.

Inflammatory tissue and an organized sinus tract are different problems. Medicine quiets inflammation. Procedures remove structures. Confusing the two leads to under-treatment in one direction and over-treatment in the other.

02

Use the smallest intervention that does the job.

Tissue preservation is a clinical priority. In the perianal, perineal, and gluteal regions especially, conservative technique is what protects function — continence, mobility, sensation. This is not a marketing line; it is the reason we built the practice around laser closure.

03

Stay coordinated with the medical team.

HS is chronic. Patients who undergo a procedure but stop their biologic, or who never had a dermatologist in the first place, do worse. We expect — and prefer — that your medical team continues their work in parallel.

Laser 1

Follicle-directed laser therapy

A long-pulsed laser delivered to the affected regions reduces the population of hair follicles whose occlusion and rupture drive HS inflammation. With fewer functional follicles, there are fewer events that can flare.

What it does

Reduces flare frequency, quiets active inflammation, and in many patients slows progression toward tunnel formation. Most useful when disease is still primarily inflammatory.

Best for

Hurley stage I and selected Hurley stage II patients. Also used pre-procedurally in some patients before CO₂ closure to quiet the surrounding field.

What it does not do

Does not close established sinus tracts. Does not replace systemic medical therapy. Does not cure HS.

Treatment course

Typically 4–6 office-based sessions spaced 4–6 weeks apart. No general anesthesia. Most patients return to ordinary activity the same day.

Full page on follicle-directed therapy →

Laser 2

CO₂ laser tunnel closure

Once HS has organized into sinus tracts, no medical therapy can close them. The CO₂ laser allows us to identify each tract, unroof it, and ablate the epithelial lining with substantially less surrounding tissue loss than wide excision.

What it does

Removes the structural disease — the tracts themselves — tract by tract, preserving as much normal tissue as the anatomy permits.

Best for

Hurley II and selected Hurley III patients with mapped, accessible tracts. Particularly suited to perianal, perineal, gluteal, and inguinal disease.

What it does not do

Does not treat active inflammation. Does not prevent new tracts from forming if the underlying inflammation is not controlled medically. Diffuse Hurley III may still require staged or excisional approaches.

Procedure setting

Outpatient operative setting, with pre-procedural mapping (clinical exam ± ultrasound or MRI). Anesthesia tailored to extent — local with sedation for most cases.

Full page on CO₂ tunnel closure →

Sequencing

How the two are sequenced

Most plans use one laser, some use both, and some use neither. The decision is made case by case, not by stage alone.

When we use both

Active inflammation plus established tracts. Follicle therapy quiets the field; CO₂ closure removes the tracts. Order depends on which dimension is dominant.

When we use one

Early disease without tracts → follicle therapy alone. Established tracts in a relatively quiet field → CO₂ closure alone, with medical co-management.

When we use neither

Medical regimen not yet optimized — we ask dermatology to lead first. Disease extent beyond our model — we refer to a reconstructive team.

Exclusions

What we do not do

A focused practice is defined as much by what it declines as by what it offers. The list below is honest, not exhaustive.

  • We do not prescribe biologics or manage your long-term medical regimen — your dermatologist or rheumatologist remains the medical lead.
  • We do not perform wide excision with flap reconstruction in our outpatient setting; when that is the right answer, we refer.
  • We do not focus on isolated axillary HS — it is well served by dermatologic surgery programs closer to most patients.
  • We do not promise cure. HS is chronic; our protocol is for durable control.
  • We do not accept cases where we believe another team would produce a better outcome. Saying no is part of the practice.

Co-management

Working with your medical team

We work alongside dermatologists and rheumatologists, not around them. Before treatment we ask for your current regimen and any imaging or biopsy reports. After treatment we send operative notes, photographs, and a written summary of what we did and what we recommend next.

Most patients continue biologic therapy through the procedural course. We coordinate timing with your prescribing physician when a brief hold is warranted; in most cases it is not.

If you do not currently have a dermatologist managing your HS, we will help you find one. Long-term medical control is what protects the result of any procedure we perform.

Cost & insurance

An honest framing

HS procedural care is variably covered. We are out-of-network for most commercial plans and provide superbills for reimbursement. Financing options are available for patients who need them. We discuss specific costs after a consultation, once the plan is defined — quoting a number before we know what the procedure entails would not be honest.

Full discussion of cost, insurance, and financing →

Recovery

What recovery looks like

Follicle therapy sessions are office-based and most patients resume ordinary activity the same day. CO₂ tunnel closure recovery depends on extent and region — most patients are back to non-strenuous activity within several days, with continued wound care for two to four weeks. We follow recovery in person and remotely.

Full recovery guide →

Next step

A consultation tells us — and tells you — whether this is the right team. We are honest when it is not.

Call (424) 279-8222WhatsApp

Typical response within one business day. We will never share your information.